NCT03709381View on ClinicalTrials.gov

Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

January 31, 2019

Conditions
Adrenal InsufficiencyOsteopenia, OsteoporosisSteroid Suppression of ACTH Secretion
Interventions
DRUG

Low Dose Cosyntropin (ACTH) stimulation test

Cosyntropin 1 mcg IV given to subjects at t=0

DRUG

High Dose Cosyntropin (ACTH) stimulation test

Cosyntropin 250 mcg IV given to subjects at t=60

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Nationwide Children's Hospital

OTHER

NCT03709381 - Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study | Biotech Hunter | Biotech Hunter